Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02644083 · ClinicalTrials.gov registry record
Tecfidera and MRI for Brain Energy in MS
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT02644083 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 4 participants.
The verdict
NCT02644083 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The primary objective of this study is to test the hypothesis that DMF can improve mitochondrial function in the brain of people with MS. The investigators will assess mitochondrial function in the cerebral grey matter by measuring PCr and ATP by 31P magnetic resonance spectroscopy (MRS) and NAA in NAWM by 1H MRS.
Interventions
- DRUG Dimethyl fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02644083
The ClinicalTrials.gov registry entry for NCT02644083 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dimethyl fumarate is the first listed.
NCT02644083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02644083 about?
NCT02644083 is a clinical study titled "Tecfidera and MRI for Brain Energy in MS". The primary objective of this study is to test the hypothesis that DMF can improve mitochondrial function in the brain of people with MS. The investigators will assess mitochondrial function in the cerebral grey matter by measuring PCr and ATP by 31P magnetic resonance spectroscopy (MRS) and NAA in ...
What is the current status of trial NCT02644083?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2016-02. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02644083?
The interventions under investigation include: Dimethyl fumarate (DRUG).
Who is sponsoring clinical trial NCT02644083?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.